APEX Compass
A 16-chapter teaching series on U.S. healthcare and insurance — Medicare, Medicaid, ACA, HIPAA, fee schedules, patient rights, and the real economics of the system. Authored by Vincent J. Lopez and updated for the 2026 policy year.
U.S. Healthcare
& Insurance
Healthcare History & The Broken Model .
U.S. healthcare did not arrive at its current form by accident. It was shaped by a century of legislation, industry lobbying, market consolidation, and perverse financial incentives - producing the most expensive, least transparent healthcare market in the developed world. The U.S. spends roughly 17–18% of GDP on healthcare — nearly double the OECD average — while ranking last among wealthy nations on access, equity, and outcomes.
Why The System Is Broken — A Diagnosis In Seven Defects
Every other developed country has converged on one of three models: single-payer (Canada, UK), multi-payer regulated insurance (Germany, Japan), or fully nationalized delivery (UK NHS). The U.S. has none of these. It has a patchwork of public programs (Medicare, Medicaid, , , ) bolted onto an employment-tied private market created by a 1940s wage-control accident, governed by a 1974 preemption that locks states out of regulating most large-employer plans. The result is a system in which no single actor is accountable for cost, quality, or coverage.
| Defect | What It Is | Downstream Consequence |
|---|---|---|
| 1. Employment-tied coverage (1942 wage-control accident) | WWII wage freezes pushed employers to compete on benefits; IRS ruled employer health contributions tax-free in 1954, locking the system in | Job loss = coverage loss. Job lock keeps workers in roles they would otherwise leave. ~155M Americans get insurance through their employer. |
| 2. ERISA preemption (1974) | Federal ERISA blocks states from regulating self-insured employer plans (~65% of employer-covered workers) | State consumer protections, balance-billing limits, and mental-health parity rules don't apply to most large employer plans |
| 3. Fee-for-service incentives | Providers paid per procedure, not per outcome. More tests, more imaging, more procedures = more revenue | Volume over value. Estimated 20–30% of U.S. healthcare spending is waste (low-value or unnecessary care) |
| 4. No price ceiling, no price floor, no public price | Hospitals set chargemaster prices arbitrarily; insurers negotiate in secret; the same MRI costs $400 or $4,000 depending on who you are | Price discrimination as business model. Uninsured pay the highest price for the same service. |
| 5. Vertical integration & consolidation | UnitedHealth owns insurer + PBM (OptumRx) + 90,000 physicians (Optum Health) + data analytics; CVS owns pharmacies + Caremark PBM + Aetna insurer | Self-dealing replaces competition. Patients can be steered to the parent company's pharmacy, clinic, or specialty drug program. |
| 6. Regulatory capture | AMA owns CPT codes (mandatory for billing); RUC (an AMA committee) recommends RVU values that CMS adopts ~90% of the time; PhRMA wrote large portions of MMA 2003 | The regulated set the rules. Specialist procedures are systematically over-valued vs. primary care. |
| 7. Administrative bloat | U.S. spends ~25–30% of healthcare dollars on administration vs. ~12% in Canada. Each insurer has its own forms, formularies, prior-auth rules, networks, appeals processes | Hospitals employ more billers than nurses in some service lines. Physicians spend ~2 hours on EHR/admin per 1 hour of patient care. |
The Subcontracting Upcharge — How One Hospital Visit Becomes Seven Bills
The single most under-explained feature of U.S. healthcare is that the “hospital” you walk into is not one company. It is a real-estate and brand wrapper around a stack of independent contractors — each with its own billing entity, its own network status, its own markup, and its own line on your final bill. The diagram below traces a single ER visit through the layers.
The Cost Comparison That Should End Every Debate
| Metric | United States | OECD Average | Best Performer |
|---|---|---|---|
| Health spending as % of GDP | ~17.3% | ~9.7% | Mexico ~5.5% (lowest); Germany ~12.7% (next-highest peer) |
| Per-capita spending (USD, PPP) | ~$13,500/year | ~$5,800/year | U.S. spends ~2.3x the average — for worse outcomes |
| Life expectancy at birth | ~76.4 years | ~80.6 years | Japan ~84.6; Switzerland ~84.0 |
| Maternal mortality (per 100k live births) | ~22.3 | ~5.0 | Norway ~1.8; Netherlands ~1.2 — U.S. ~10x worse than peers |
| Avoidable deaths (per 100k) | ~336 | ~225 | Switzerland ~165 — U.S. has ~50% more avoidable deaths |
| Adults skipping care due to cost | ~38% | ~10% | U.K., Norway, Germany ~5–8% |
| Adults with medical debt | ~41% | <5% | Most peer nations report essentially none |
| Administrative cost share | ~25–30% | ~12% | Canada ~12%; Japan ~13% |
The Legislative Timeline
| Year | Law / Event | Impact |
|---|---|---|
| 1946 | Hill-Burton Act (P.L. 79-725) | Federal funds to build hospitals; required charity care - still enforceable at 170+ facilities today |
| 1965 | Social Security Amendments (P.L. 89-97) | Created Medicare (Title XVIII) and Medicaid (Title XIX); government became largest health payer overnight |
| 1973 | HMO Act (P.L. 93-222) | Federally encouraged managed care; employers with 25+ employees required to offer HMO option |
| 1974 | ERISA | Federal preemption of state insurance law for self-insured employer plans; blocked many consumer protections for decades |
| 1982 | TEFRA / DRG System | Medicare shifted from cost-based to DRG prospective payment; hospitals incentivized to discharge faster |
| 1986 | EMTALA | Medicare hospitals must screen and stabilize emergency patients regardless of ability to pay - un-funded mandate |
| 1986 | COBRA | Continuation coverage rights after job loss; employee pays full premium (up to 102%) |
| 1996 | HIPAA | Health data privacy, security, portability rules; fraud enforcement strengthened |
| 1997 | BBA / CHIP | Created Medicare+Choice (later MA); created CHIP (Title XXI) |
| 2003 | MMA | Created Medicare Part D; HSAs; renamed Medicare Advantage |
| 2009 | ARRA / HITECH | $19B EHR adoption incentive; Meaningful Use; strengthened HIPAA |
| 2010 | ACA (P.L. 111-148) | Medicaid expansion; exchanges; EHB mandate; pre-existing condition ban; CMMI |
| 2015 | MACRA | Repealed SGR; QPP; closed Medigap Plans C/F to new enrollees post-2020 |
| 2016 | 21st Century Cures Act | Information blocking prohibition; FHIR mandates; ONC authorities expanded |
| 2022 | No Surprises Act | Surprise billing protections; IDR; Good Faith Estimates for uninsured patients |
| 2022 | Inflation Reduction Act | CMS drug price negotiation (first time ever); $2,000 Part D OOP cap (2025); ACA subsidy extension |
The Chargemaster System: Arbitrary Pricing
Every hospital maintains a Charge Description Master () - an internal price list for every service, drug, and supply. These “chargemaster” prices are essentially arbitrary, often 2-10x what any payer actually pays. No federal law limits chargemaster prices.
| Price Layer | What It Is | Who Pays It |
|---|---|---|
| Chargemaster (CDM) | Hospital sticker price; no regulatory ceiling | Uninsured patients who don't negotiate; some OON scenarios |
| Medicare-Allowed Amount | Set annually by CMS fee schedule | Medicare beneficiaries + supplemental insurers |
| Medicaid Rate | State-negotiated; typically below Medicare rates | Medicaid enrollees |
| Commercial Negotiated Rate | % of Medicare or CDM; privately negotiated | Insured patients (after deductible/coinsurance) |
| Patient OOP | After insurance applies | The patient - deductible + coinsurance |
Nonprofit Hospitals: The Tax-Exemption Problem
Approximately 58% of community hospitals are tax-exempt nonprofits under IRC Section 501(c)(3) - paying no federal, state, or local income tax, often no property tax, and able to issue tax-exempt bonds. In exchange, they must provide “community benefit” - but the IRS definition is so broad as to be nearly unenforceable.
| Requirement | The Reality |
|---|---|
| Provide charity care | No minimum dollar amount required by federal law; hospitals self-report on Form 990 |
| Community benefit | Can include executive salaries counted as 'health education,' marketing, research overhead |
| Tax exemption value | Estimated $37.4 billion/year combined federal, state, and local (2020 estimate) |
| Actual charity care | Many large nonprofit systems provide charity care equal to 1-3% of total expenses |
| Executive compensation | CEO salaries at major systems routinely exceed $5-10M/year; publicly disclosed on Form 990 |
| Federal enforcement | Extremely rare; state attorneys general are primary oversight but chronically under-resourced |
Contracted Staff: The Hidden Billing Layer
Most patients assume they are seeing hospital employees. In reality, emergency medicine, anesthesiology, radiology, pathology, and hospitalist departments are commonly staffed by private groups or staffing corporations contracted to the hospital - creating separate billing entities.
| Reality | Patient Impact |
|---|---|
| Separate billing entity | Bills from both hospital (facility fee) and physician group (professional fee) - often different companies |
| Out-of-network surprise billing | Contracted group may be out-of-network even if the hospital is in-network - origin of the surprise billing crisis |
| Private equity staffing firms | TeamHealth, Envision, and similar PE-owned firms prioritize volume billing and coding intensity |
| Locum tenens physicians | Temporary/traveling physicians; premium rates; patient often unaware; costs passed through |
| No Surprises Act (2022) | Now prohibits most surprise bills in emergency and non-emergency settings |
GPOs - Group Purchasing Organizations
PBMs - Pharmacy Benefit Managers
PBMs manage drug benefits for insurers, employers, and Part D plans. The top three - Express Scripts (Cigna), CVS Caremark, OptumRx (UnitedHealth) - control ~80% of the market and have vertically integrated with insurers, pharmacies, and providers.
| PBM Function | How It Creates Cost |
|---|---|
| Formulary management | Drug makers pay 'rebates' to secure preferred formulary placement; list prices inflated to fund rebates |
| Rebate retention | PBMs historically kept a portion of manufacturer rebates rather than passing savings to patients |
| Spread pricing | PBM charges plan more than it pays pharmacy; keeps the difference ('spread') - opaque to all parties |
| Vertical integration | UnitedHealth (insurer) - OptumRx (PBM); CVS (pharmacy) - Caremark (PBM) - one company controls the pipeline |
| DIR fees | Retroactive fees charged to pharmacies after point of sale - unpredictable and ultimately raising costs |
| IRA 2022 reform | Required Part D drug rebates passed to beneficiaries at point of sale beginning 2025 |
Facility Fees & Price Transparency Rules
When hospitals acquire physician practices, they can charge a “facility fee” for visits that previously generated only a professional fee. Same office, same doctor - but two bills now arrive: a facility (technical) component and a professional component.
| Price Transparency Rule | Effective | Requirement |
|---|---|---|
| Hospital Price Transparency (CMS) | Jan 1, 2021 | Machine-readable files of all standard charges; shoppable services estimator; fines up to $2M/year for non-compliance |
| Transparency in Coverage (TiC) | 2022 | Insurers must publish negotiated rates for all in-network providers and out-of-network allowed amounts |
| Good Faith Estimate (NSA) | Jan 1, 2022 | Providers must give uninsured/self-pay patients a written cost estimate before scheduled services; dispute if final bill exceeds estimate by $400+ |
Tip: press ⌘K inside the reader to search every chapter and glossary term.